March 07, 2022
Mallinckrodt ARD LLC has agreed to pay $260 million to resolve government allegations that it underpaid Medicaid rebates for its Acthar gel products and paid illegal kickbacks to induce Medicare patients to buy its drugs, the U.S. Department of Justice said Monday.
July 13, 2020
The government is wrongly conflating fraud with a regulatory disagreement, Mallinckrodt ARD LLC told a Massachusetts federal court Monday, urging a judge to toss False Claims Act claims centering on its pricey H.P. Acthar Gel drug, which treats infantile spasms and other conditions.
March 03, 2020
Mallinckrodt ARD Inc. shortchanged Medicaid by hundreds of millions of dollars as the company hiked the price of its drug H.P. Acthar Gel, the U.S. Department of Justice alleged in a False Claims Act suit unsealed Tuesday in Massachusetts.